Telomerase reverse transcriptase-based therapies
US11529396B2 · kind B2 · utility
0Cited by
0References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 4, 2015 |
| Grant date | Dec 20, 2022 |
| Priority date | — |
| Expiry date | Dec 26, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2750/14145
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides compositions and methods useful for the treatment and prevention of conditions associated with short telomere length.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.